Company news
Gossamer Bio, Inc. news in 2020
Gossamer Bio, Inc.'s news releases, calls and decks from 2020, newest first.
Aerpio Announces Statistically Significant Topline Results from Razuprotafib Glaucoma Phase 2 Trial
December 10, 2020
Gossamer Bio to Host Webcast Focused on GB002 and Pulmonary Arterial Hypertension (PAH) on December 15, 2020
December 6, 2020
Gossamer Bio Announces Appointment of Faheem Hasnain as Chief Executive Officer
November 15, 2020
Gossamer Bio Announces Third Quarter 2020 Financial Results and Provides Corporate Update
November 9, 2020
Gossamer Bio to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 10, 2020
November 5, 2020
Gossamer Bio Announces GB1275 Data Presentations at 2020 Society for Immunotherapy of Cancer Annual Meeting
November 5, 2020
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
October 12, 2020
Gossamer Bio Announces Presentation of GB004 Phase 1b Clinical Data at United European Gastroenterology Virtual Week 2020 and Additional Program Updates
October 11, 2020
Gossamer Bio Announces GB004 Data Presentations at United European Gastroenterology Virtual Week 2020
October 8, 2020
Gossamer Bio Announces Participation in Upcoming Investor Conferences
September 9, 2020
Gossamer Bio Announces Data Presentations at the Virtual European Respiratory Society International Congress 2020
September 6, 2020
Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-ill COVID-19 Patients
August 31, 2020
Gossamer Bio Announces Second Quarter 2020 Financial Results and Provides Corporate Update
August 10, 2020
Gossamer Bio Announces Data Presentations at the American Thoracic Society 2020 Virtual Conference
August 4, 2020
Gossamer Bio Announces Early Encouraging Safety and Biomarker Data from Phase 1/2 Study of GB1275 at American Society of Clinical Oncology 2020 Virtual Scientific Program
May 28, 2020
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes Due 2027
May 17, 2020
Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
May 11, 2020
Gossamer Bio to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 12, 2020
May 7, 2020
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
March 23, 2020
Gossamer Bio Announces Participation in 9th Annual SVB Leerink Global Healthcare Conference
February 17, 2020
Gossamer Bio Announces Data Presentations at the Congress of the European Crohn’s and Colitis Organisation
February 12, 2020
Gossamer Bio Announces Data Presentation at the 2020 Crohn’s & Colitis Congress
January 22, 2020
Calls in 2020
Decks in 2020
- Technical Presentation (October 2020)
Technical · 23 slides · Oct 13, 2020